UBS Group’s Lam Research LRCX Stock Holding History

UBS Group’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.39B	Sell	6,526,433 -1,254,621	-16%	-$281M	0.21%	79
2025 Q4	$1.33B	Buy	7,781,054 +356,490	+5%	+$55.4M	0.22%	76
2025 Q3	$994M	Sell	7,424,564 -2,451,569	-25%	-$260M	0.16%	107
2025 Q2	$961M	Sell	9,876,133 -565,522	-5%	-$44.9M	0.17%	105
2025 Q1	$759M	Buy	10,441,655 +497,437	+5%	+$39.2M	0.14%	137
2024 Q4	$718M	Buy	9,944,218 +2,380,238	+31%	+$181M	0.13%	145
2024 Q3	$617M	Buy	7,563,980 +1,436,770	+23%	+$125M	0.13%	145
2024 Q2	$652M	Sell	6,127,210 -332,550	-5%	-$31.9M	0.16%	119
2024 Q1	$628M	Sell	6,459,760 -423,050	-6%	-$37.2M	0.16%	122
2023 Q4	$539M	Buy	6,882,810 +1,159,610	+20%	+$79M	0.16%	125
2023 Q3	$359M	Buy	5,723,200 +375,240	+7%	+$24.7M	0.12%	160
2023 Q2	$344M	Buy	5,347,960 +158,350	+3%	+$8.93M	0.12%	180
2023 Q1	$275M	Sell	5,189,610 -22,730	-0.4%	-$1.12M	0.1%	199
2022 Q4	$219M	Buy	5,212,340 +733,280	+16%	+$30.7M	0.08%	251
2022 Q3	$164M	Sell	4,479,060 -2,079,000	-32%	-$92.6M	0.07%	279
2022 Q2	$279M	Buy	6,558,060 +1,329,580	+25%	+$63.3M	0.11%	192
2022 Q1	$281M	Buy	5,228,480 +1,414,940	+37%	+$82.4M	0.09%	222
2021 Q4	$274M	Sell	3,813,540 -1,836,820	-33%	-$115M	0.08%	256
2021 Q3	$322M	Buy	5,650,360 +16,610	+0.3%	+$1.01M	0.1%	203
2021 Q2	$367M	Sell	5,633,750 -211,280	-4%	-$13.3M	0.12%	173
2021 Q1	$348M	Buy	5,845,030 +949,910	+19%	+$51.8M	0.12%	186
2020 Q4	$231M	Buy	4,895,120 +612,770	+14%	+$25.8M	0.08%	254
2020 Q3	$142M	Buy	4,282,350 +1,689,800	+65%	+$58.2M	0.05%	311
2020 Q2	$83.9M	Sell	2,592,550 -1,178,930	-31%	-$32.2M	0.04%	425
2020 Q1	$90.5M	Sell	3,771,480 -27,700	-0.7%	-$798K	0.04%	373
2019 Q4	$111M	Sell	3,799,180 -195,010	-5%	-$5.18M	0.04%	421
2019 Q3	$92.3M	Buy	3,994,190 +73,580	+2%	+$1.54M	0.04%	428
2019 Q2	$73.6M	Buy	3,920,610 +737,700	+23%	+$14M	0.03%	501
2019 Q1	$57M	Buy	3,182,910 +299,360	+10%	+$5M	0.02%	574
2018 Q4	$39.3M	Sell	2,883,550 -1,204,010	-29%	-$17.3M	0.02%	711
2018 Q3	$62M	Sell	4,087,560 -1,034,800	-20%	-$17.7M	0.02%	579
2018 Q2	$88.5M	Sell	5,122,360 -339,260	-6%	-$6.53M	0.04%	432
2018 Q1	$111M	Buy	5,461,620 +171,860	+3%	+$3.4M	0.05%	358
2017 Q4	$97.4M	Buy	5,289,760 +23,460	+0.4%	+$461K	0.04%	418
2017 Q3	$97.4M	Sell	5,266,300 -420,220	-7%	-$6.82M	0.05%	378
2017 Q2	$80.4M	Sell	5,686,520 -583,010	-9%	-$8.55M	0.04%	406
2017 Q1	$80.5M	Buy	6,269,530 +3,240,060	+107%	+$38.1M	0.04%	396
2016 Q4	$32M	Buy	3,029,470 +142,180	+5%	+$1.44M	0.02%	746
2016 Q3	$27.3M	Buy	2,887,290 +499,240	+21%	+$4.54M	0.02%	791
2016 Q2	$20.1M	Sell	2,388,050 -115,230	-5%	-$926K	0.01%	934
2016 Q1	$20.7M	Sell	2,503,280 -669,090	-21%	-$4.87M	0.01%	866
2015 Q4	$25.2M	Sell	3,172,370 -5,645,660	-64%	-$42.5M	0.02%	832
2015 Q3	$57.6M	Buy	8,818,030 +1,973,080	+29%	+$14.5M	0.04%	425
2015 Q2	$55.7M	Sell	6,844,950 -460,840	-6%	-$3.62M	0.04%	483
2015 Q1	$51.3M	Buy	7,305,790 +361,680	+5%	+$2.86M	0.04%	496
2014 Q4	$55.1M	Buy	+6,944,110	New	+$53.8M	0.04%	498

Other funds holding LRCX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group's LRCX Position: Q1 2026 in Review

UBS Group reduced its Lam Research (LRCX) stake by 16% in Q1 2026, selling an estimated $281M and leaving 6,526,433 shares worth $1.39B. The position accounts for 0.21% of the portfolio, ranked #79.

UBS Group first reported a position in LRCX in Q4 2014 and has held it in 46 quarters since. 2,632 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

UBS Group held 6,526,433 shares of Lam Research worth $1.39B as of Q1 2026.
UBS Group sold 1,254,621 Lam Research shares in Q1 2026, an estimated $281M.
Lam Research made up 0.21% of UBS Group's portfolio in Q1 2026, its #79 holding.
UBS Group first reported a position in Lam Research in Q4 2014 and has held it in 46 quarters since.
2,632 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.